NIH-funded research R01 grant

Sodium-related edema in nephrotic syndrome and ANGPTL4

Official title: Sodium-independent mechanisms of edema in nephrotic syndrome

Funded at Rush University Medical Center · NIH-11431977 · Data updated 2026-11-12

A physician-scientist group is studying how a protein called ANGPTL4 may drive skin edema in nephrotic syndrome, with experiments in rodents and tests on human ANGPTL4 fragments.

More Nephrotic Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$749,087
NIH project number1R01DK148785-01
Project IDNIH-11431977 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with nephrotic syndrome or clinicians treating such patients, whose biology may be reflected in ANGPTL4 pathways.

Less likely to help

Patients without nephrotic syndrome or ANGPTL4-related edema may not directly benefit.

What this research studies

This project looks at why people with nephrotic syndrome accumulate fluid by focusing on ANGPTL4, a circulating protein. Researchers will induce nephrotic syndrome in rats, measure edema with multiple methods, and create lab tests using skin endothelial cells. They will also examine different ANGPTL4 forms and map the parts that drive edema, including 3D skin imaging and structural studies. The goal is to identify which ANGPTL4 form causes capillary leakage so future therapies can target it.

Why it matters

Potential benefit: If successful, this work could lead to targeted therapies that reduce swelling in nephrotic syndrome by blocking the key ANGPTL4 fragment.

How similar studies have gone: Previous animal studies suggest ANGPTL4 influences edema; this project aims to clarify which fragment is responsible and how it works.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Chugh, Sumant Singh — Rush University Medical Center
  • Study coordinator: Chugh, Sumant Singh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.